4.78
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NEOG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$4.73
Offen:
$4.69
24-Stunden-Volumen:
8.69M
Relative Volume:
1.30
Marktkapitalisierung:
$1.27B
Einnahmen:
$912.20M
Nettoeinkommen (Verlust:
$-23.53M
KGV:
-41.57
EPS:
-0.115
Netto-Cashflow:
$-124.88M
1W Leistung:
+0.21%
1M Leistung:
-18.43%
6M Leistung:
-60.63%
1J Leistung:
-69.42%
Neogen Corp Stock (NEOG) Company Profile
Firmenname
Neogen Corp
Sektor
Branche
Telefon
(517) 372-9200
Adresse
620 LESHER PLACE, LANSING
Vergleichen Sie NEOG mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NEOG
Neogen Corp
|
4.78 | 1.27B | 912.20M | -23.53M | -124.88M | -0.115 |
![]()
TMO
Thermo Fisher Scientific Inc
|
405.46 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
197.54 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
536.34 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
118.01 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
157.59 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Neogen Corp Stock (NEOG) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-19 | Eingeleitet | Guggenheim | Buy |
2023-06-16 | Eingeleitet | Wells Fargo | Overweight |
2022-11-22 | Hochstufung | William Blair | Mkt Perform → Outperform |
2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
2019-05-23 | Eingeleitet | Guggenheim | Neutral |
2017-12-05 | Fortgesetzt | ROTH Capital | Neutral |
2017-07-14 | Eingeleitet | CL King | Neutral |
2014-06-05 | Eingeleitet | William Blair | Mkt Perform |
2011-03-31 | Hochstufung | Hilliard Lyons | Underperform → Neutral |
2009-09-25 | Bestätigt | Roth Capital | Buy |
2009-07-22 | Bestätigt | Roth Capital | Buy |
2009-03-20 | Bestätigt | Roth Capital | Buy |
2009-01-07 | Bestätigt | Roth Capital | Buy |
2008-09-25 | Bestätigt | Roth Capital | Buy |
2008-01-04 | Bestätigt | Roth Capital | Buy |
2007-09-28 | Bestätigt | Roth Capital | Buy |
2007-07-25 | Bestätigt | Roth Capital | Buy |
2007-07-09 | Bestätigt | Roth Capital | Buy |
2007-05-08 | Eingeleitet | Susquehanna Financial | Positive |
Alle ansehen
Neogen Corp Aktie (NEOG) Neueste Nachrichten
Neogen (NASDAQ:NEOG) Shares Down 3.9%Time to Sell? - MarketBeat
Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm - GlobeNewswire Inc.
Rhumbline Advisers Lowers Stock Holdings in Neogen Co. (NASDAQ:NEOG) - MarketBeat
Neogen (NASDAQ:NEOG) Shares Down 2.9%Here's Why - MarketBeat
Harbor Capital Advisors Inc. Boosts Stock Holdings in Neogen Co. (NASDAQ:NEOG) - MarketBeat
Zacks Research Issues Negative Estimate for Neogen Earnings - MarketBeat
Bridge City Capital LLC Has $3.74 Million Position in Neogen Co. (NASDAQ:NEOG) - MarketBeat
NEOG Investors Have Opportunity to Join Neogen Corporation Fraud Investigation with the Schall Law Firm - Business Wire
Neogen (NASDAQ:NEOG) Stock Price Up 7.1%Here's Why - MarketBeat
FY2026 Earnings Estimate for Neogen Issued By Zacks Research - MarketBeat
Zacks Research Has Pessimistic Outlook of Neogen Q2 Earnings - Defense World
Neogen (NASDAQ:NEOG) Stock Price Down 12.6%What's Next? - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Holdings in Neogen Co. (NASDAQ:NEOG) - MarketBeat
Neogen releases second edition of environmental monitoring handbook - Dairy Foods Magazine
New Food Safety Guide by Cornell Experts Reveals Advanced Contamination Prevention Strategies - Stock Titan
69,159 Shares in Neogen Co. (NASDAQ:NEOG) Bought by Squarepoint Ops LLC - MarketBeat
Neogen And Dollar Tree Face Earnings Pressure As Stocks Take A Hit - Finimize
Why Neogen (NEOG) Stock Is Down Today - Yahoo Finance
Neogen stock tumbles on genomics business divestiture plans - Investing.com
Neogen at William Blair Conference: Strategic Integration and Market Outlook - Investing.com
Neogen (NEOG) Stock Drops on Q4 Fiscal 2025 Outlook and Strategi - GuruFocus
Forensic Genomics Market Research 2025Global Trends, Opportunity, and Forecasts 2020-2030 - GlobeNewswire Inc.
Neogen (NEOG) Stock Drops on Q4 Fiscal 2025 Outlook and Strategic Updates - GuruFocus
Neogen (NASDAQ:NEOG) Shares Up 4.8%Here's What Happened - MarketBeat
Mackenzie Financial Corp Acquires 423,923 Shares of Neogen Co. (NASDAQ:NEOG) - MarketBeat
Nuveen Asset Management LLC Decreases Position in Neogen Co. (NASDAQ:NEOG) - Defense World
Deutsche Bank AG Has $2.29 Million Holdings in Neogen Co. (NASDAQ:NEOG) - MarketBeat
Neogen Co. (NASDAQ:NEOG) Shares Sold by Lazard Asset Management LLC - MarketBeat
BNP Paribas Financial Markets Has $524,000 Position in Neogen Co. (NASDAQ:NEOG) - Defense World
Neogen Co. (NASDAQ:NEOG) Shares Bought by Deutsche Bank AG - Defense World
Neogen Stock Gains Following Strategic Alliance With Syngenta - MSN
Shapiro Capital Management LLC Increases Stake in Neogen Co. (NASDAQ:NEOG) - MarketBeat
Select Equity Group L.P. Cuts Holdings in Neogen Co. (NASDAQ:NEOG) - MarketBeat
Neogen CFO David Naemura to Share Strategic Insights at William Blair Growth Conference - Stock Titan
Bank of America Corp DE Has $43.45 Million Stake in Neogen Co. (NASDAQ:NEOG) - MarketBeat
Janus Henderson Group PLC Has $40.11 Million Stake in Neogen Co. (NASDAQ:NEOG) - MarketBeat
Syngenta, Neogen Enter Licensing Agreement for Brodifacoum Rodenticides - Pest Control Technology
Neogen Co. (NASDAQ:NEOG) Shares Purchased by Silvercrest Asset Management Group LLC - MarketBeat
Mercer Global Advisors Inc. ADV Decreases Position in Neogen Co. (NASDAQ:NEOG) - Defense World
Neogen Co. (NASDAQ:NEOG) Director Aashima Gupta Purchases 16,000 Shares - MarketBeat
Finanzdaten der Neogen Corp-Aktie (NEOG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Neogen Corp-Aktie (NEOG) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Moylan John Patrick | Chief Accounting Officer |
May 01 '25 |
Option Exercise |
5.15 |
4,558 |
23,474 |
14,558 |
ADENT JOHN EDWARD | CEO |
Apr 28 '25 |
Option Exercise |
5.16 |
2,112 |
10,898 |
271,276 |
Jones Douglas Edward | Chief Operating Officer |
Apr 28 '25 |
Option Exercise |
5.16 |
845 |
4,360 |
72,004 |
Rocklin Amy M | Chief Legal Officer |
Apr 28 '25 |
Option Exercise |
5.16 |
564 |
2,910 |
36,851 |
Woteki Catherine E | Director |
Apr 25 '25 |
Buy |
5.17 |
5,770 |
29,831 |
13,244 |
BOREL JAMES C | Director |
Apr 24 '25 |
Buy |
4.99 |
30,000 |
149,700 |
90,474 |
BOEHM WILLIAM T | Director |
Apr 24 '25 |
Buy |
5.24 |
5,000 |
26,175 |
36,214 |
BOREL JAMES C | Director |
Apr 24 '25 |
Buy |
4.89 |
35,000 |
171,290 |
60,474 |
Rocklin Amy M | Chief Legal Officer |
Apr 23 '25 |
Buy |
4.99 |
12,500 |
62,375 |
36,287 |
CAPELLO JEFFREY D | Director |
Apr 22 '25 |
Buy |
4.84 |
20,712 |
100,217 |
26,629 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):